This article has Open Peer Review reports available.
Reversible hypothyroidism and Whipple's disease
© Tran; licensee BioMed Central Ltd. 2006
Received: 29 September 2005
Accepted: 10 May 2006
Published: 10 May 2006
The major cause of primary hypothyroidism is autoimmune mediated with progressive and permanent destruction of the thyroid gland resulting in life-long replacement therapy. Treatable and reversible hypothyroidism is unusual and here forth is such a case due to infection of the thyroid gland with Tropheryma whippleii, Whipple disease.
A 45 year-old female presented with symptoms and signs consistent with primary hypothyroidism, which was also confirmed biochemically. Her response to thyroxine replacement therapy was poor however, requiring a significantly elevated amount. Further investigation revealed the presence of Whipple's disease involving the gastrointestinal trace and possibly the thyroid gland. Her thyroxine requirement decreased drastically following appropriate antimicrobial therapy for Whipple's disease to the extent that it was ceased. Thyrotropin releasing hormone testing in the steady state suggested there was diminished thyroid reserve due to Whipple's disease.
This is the first ante-mortem case report studying the possible involvement of the thyroid gland by Whipple's disease. Despite the normalization of her thyroid function test biochemically after antibiotic therapy, there is diminished thyroid reserve thus requiring close and regular monitoring.
A 45-year-old female presents with a 6-month history of progressive tiredness, lethargy and mild, intermittent alopecia. She also reported mild shortness of breath and ankle swelling. Her family has noted a slowed mentation with approximately 8 kg weight loss (~10% of body weight) during this time. There was no fever, diarrhea, abdominal pain, malaise or arthralgia on systemic review. She has never smoked and there was no significant past history. No first-degree relative had any history of thyroid disease.
Laboratory Parameters. (Numbers in parentheses represent the reference ranges.)
Haemoglobin (115–165 g/L)
White cell count (4.0–11.0 × 109 per L)
Platelet count (150–400 × 109 per L)
Erythrocyte Sedimentation Rate (<10 mm/hr)
Potassium (3.5–5.5 mmol/L)
Urea (3.6–6.8 mmol/L)
Creatinine (0.06–0.10 mmol/L)
Glucose (random) (3.0–7.7 mmol/L)
Calcium (2.18–2.50 mmol/L)
Ionised Calcium (1.04–1.24 mmol/L)
Phosphate (0.86–1.36 mmol/L)
CK (<120 U/L)
Total Cholesterol (<4.0 mmol/L)
Triglyceride (<1.8 mmol/L)
Iron (10–27 umol/L)
Ferritin (30–260 ug/L)
Transferrin (2.0–3.8 g/L)
Total iron binding capacity (48–68 umol/L)
Albumin (35–42 g/L)
Total protein (67–79 g/L)
TSH (0.4–4.0 mU/L)
Free tetra-iodothyronine (10.5–26.5 pmol/L)
Anti-thyroglobulin antibody titre (<1:100)
Anti-thyroperoxidase antibody titre (<1:100)
TSH Stimulating Immunoglobulin (<10 U/mL)
Levo-thyroxine was initiated but with very little improvement in her symptoms despite assured compliance. At 6 weeks' review, her thyrotropin (TSH) remained at 75 mU/L on 100 μg of L-thyroxine daily. The dose was adjusted according to clinical symptoms and TSH values every 6–8 weeks. The latter was 66 mU/L on 200 μg of L-thyroxine, 52 mU/L on 300 μg and 58 mU/L on 400 μg daily. Finally, she was maintained on 500 μg daily with steady state TSH of 24.5 mU/L despite moderate improvement in symptoms only. Malabsorption then became evident given her biochemical parameters (Table 1) and the 1 mg-thyroxine absorption test confirmed such suspicion. Her fT4 concentrations rose modestly. Levels were 5.6, 7.8 and 8.1 pmol/L at 0, 2 and 4 hours respectively. Her anti-transglutaminase antibody was normal, ruling out Coeliac's disease. As her symptoms persisted, an upper gastrointestinal endoscopy was performed which revealed, surprisingly, a normal duodenal mucosal appearance. Unfortunately, enteroscopic photography was not available.
Diagnostic procedures for Whipple's disease (WD)
Two attempts at thyroid cytology aspirations were performed to identify the presence of TW. Unfortunately, both failed to extract adequate DNA to perform the identification of 16S rDNA by PCR amplification and sequencing. Cytological examination showed the presence of cellular inflammatory infiltrates including a small number of lymphocytes, which were PAS-negative.
The patient was diagnosed with WD and treated with Trimethoprim-Sulphamethoxazole (Bactrim) during which she improved steadily and regained in reasonable health in the following 6 months. She was able to return to work as an assistant librarian, albeit part-time. A formal neurological assessment was not performed including cerebral magnetic resonance imaging and cerebral spinal fluid examination.
She then developed tremor and palpitation and her TSH was found to be suppressed mandating thyroxine cessation. The patient remained off thyroxine and follow-ups at 6 and 12 months showed a TSH of 2.6, 1.5 mU/L with fT4 of 15.8 and 20.5 pmol/L respectively.
Long term follow-up included close monitoring of her thyroid status. A repeat of her TRH stimulation test was performed at 36 months was near identical to previous. No repeat endoscopy and small bowel biopsy were performed as clinical progress was satisfactory.
WD was historically considered a primarily gastrointestinal disease with diarrhoea being the predominant symptom. However, it is now widely accepted as a generalized systemic disease involving many organs. The case report is atypical in that patient concerned is female with few gastrointestinal symptoms [3, 4]. The diagnostic procedures available for the diagnosis of WD include small bowel biopsy (SBB), EM findings and PCR. The appearance of the SBB and relevant stainings are non-specific . EM, which some considered diagnostic, is time consuming and is not routinely available. Similarly, PCR is useful but is technically challenging. To further confound the issue, TW detection using PCR has been found in salivary content of healthy subjects from England , sewage treatment plants  and gastric juice and duodenum of patients with no clinical signs or suspicion of WD . Thus these three tools are non-specific on their own but a combination of any two positive results can contribute to the diagnosis . Immunohistochemistry, staining for the PAS containing granules in the bacteria, is pivotal in the diagnosis. Cross-reaction is very low (with Shigella and Streptococcus agalactiae) and thus is very useful . However, this test is highly specialized, not readily and routinely available due to the rarity of the disease and hence could not be performed. Recently, culture of the organism has become possible but with great difficulties due to the organism's slow growth with the calculated doubling time of 18 days. Therefore this great advance remains mostly in the research setting [5, 10]. Where possible, culture for organisms that can mimic the histological findings of WD, such as Mycobacterium tuberculosis, should be carried out as the results will heavily influence the choice of antimicrobial therapy . Thus, due to restricted availability of diagnostic tests, the diagnosis relies heavily on the combination of clinical symptoms and signs, response to empirical and appropriate antibiotic and relevant investigations where available.
The first alert to the malabsorption was the failure to normalize TSH despite an incremental increase in thyroxine dosage to above 1.6 μg/kg/day , the general dose required dose to achieve euthyroidism. Additionally, the biochemical parameters were suggestive of the condition and this was further supported by the failure of serum thyroxine to rise following the 1 mg-thyroxine absorption test. The low serum protein including albumin and presumably transthyretin (pre-albumin) would avail less binding sites for the absorbed thyroxine and thus a relatively higher level of free (active) thyroxine to exert its effect upon peripheral tissues. Thus, this may have moderated the degree of hypothyroidism symptomatically. A trial of lio-thyronine (synthetic tri-iodothyronine) would have provided additional evidence of malabsorption. The lowering of TSH concentration at considerably higher doses of thyroxine suggested there was some absorption, probably from the large bowel . However, as most of the thyroxine is absorbed from the ileum, this is consistent with the fact that WD commonly involves all portion of the small bowel and rarely the colon. This was the primary reason for the lack of response to thyroxine supplement.
It is highly probable that the WD putatively involved the thyroid as evident by the concomitant presence of hypothyroidism, the absence of thyroid auto-immunity and the recovery of normal thyroid function following antibiotic therapy, albeit with reduced thyroid reserve (see below). Further evidence stems from the fact that TW has been detected in many extra-intestinal organs ranging from cardiac valves, synovium, lung and pituitary [13–16] resulting in the corresponding clinical symptoms. In addition, the thyroid volume was slighted increased , suggesting the presence of oedema and inflammation. The thyroid nuclear uptake scan was inconclusive however. The seeding of the thyroid with TW is likely to be haemotogenous in nature given the TW PCR positivity in circulating mononuclear cells (MNC). Evidence of antibiotic effectiveness was also evident by the clearance of TW from circulating MNC and presumably thyroid tissue. It is appreciated however that the correlation between systemic Whipple's disease and its PCR positivity is far from perfect and the use of MNC PCR to monitor response to therapy remains controversial at this stage [15, 17]. It is also critical that the diagnosis of TW-induced hypothyroidism was one of exclusion after other causes of hypothyroidism have been adequately excluded including negative/normal thyroid autoantibody studies including TSI. Ord's disease can cause transient hypothyroidism in the presence of negative anti-TPO and anti-Tg but the duration of hypothyroidism was probably too long for this to be the case. Also, the autoantibody titres mentioned remained unchanged overtime.
The gold standard for a reassessment of the condition would be a re-examination of the small bowel tissue for the clearance of the organism and resumption of normal bowel architecture. The patient, not unreasonably however, declined a repeat endoscopy due to a marked improvement in clinical response to antibiotic. It should be noted that WD and its characteristic PAS-positive granules on biopsy can remain positive for years after the treatment has been completed . Presumably then duodenal tissue PCR for TW also remains positive for the same reasons, illustrating the discrepancy between clinical and histopathologic response. It remains to be seen if these two entities represent an unviable or simply dormant organism.
Although TW has been reported to involve the central nervous system in up to 90% of cases at postmortem examination , no such assessment was considered in this case due to the absence of neurological signs and excellent clinical progress. Agreeably, a proportion of WD involving the CNS will go undiagnosed .
Although the infection plausibly involved the thyroid, destruction must have been incomplete for euthyroidism to return. There might have been oedema and partial damage, impairing thyroid follicular function but with enough residual tissue to recover to euthyroidism. Previous postmortem report found complete obliteration of the thyroid gland with fibrous tissues . There were foci of lymphocytes and cells containing PAS granules, which were not detected albeit in the FNA sample in this report. Contrary to intestinal villi from the gastrointestinal tract, which could be readily regenerated, thyroid tissues are not and thus it is assumed that some, but not all thyroid tissues are destroyed by the infective process. This is consistent with a previous case report  in which there was permanent panhypopituitarism despite the clearance of TW (as performed by PCR) after 4 weeks of appropriate antibiotic. Unfortunately and despite repeated attempts, direct evidence of TW involving the thyroid could not be obtained either by direct culture or PCR.
In order to assess thyroid reserve at the end of therapy, the TRH stimulation test was performed and revealed an exaggerated TSH response indicating impaired thyroid reserve [21, 22]. This test was performed 18 months after the initial diagnosis of primary hypothyroidism to ensure that thyrotrophic cells have recovered from hyperplasia that can persist for weeks to months in primary hypothyroidism, even in the face of subsequent short-lived exogenous thyrotoxicosis. Thyrotrophic hyperplasia needed to be excluded because this can cause an augmented TRH-stimulated response in hypothyroidism and therefore may not reflect the patient's true thyroid status. In the absence of any other factors that may impair thyroid reserve, including smoking, iodine depletion and subclinical autoimmune thyroiditis, the demonstrated and diminished thyroid reserve can be attributed to TW infection. The patient is, of course, at risk of rapid and progressive hypothyroidism when the abovementioned risk factors intervened and hence requires frequent monitoring. As the TRH tests are unchanged and her TSH levels have remained normal so far, it can be deduced with confidence that the destructive inflammatory process incited by the presence of TW has been arrested but the damage permanent with a reduced thyroid reserve.
The case highlights thyroid involvement by TW, causing significant thyroid failure. Despite the evidence of TW present in the duodenum and circulating leucocytes, its presence in thyroid tissue could not only be indirectly proven. However, the successful reversibility of the primary hypothyroidism in response to long-term anti-biotic therapy indicates strongly that WD indeed involves the thyroid gland in the absence of alternative causes. The damage to the thyroid has also resulted in permanent and reduced thyroid reserve as demonstrated by repeated TRH stimulation tests but with normal thyrotropin levels. This is only the second report that convincingly describes the putative link between primary hypothyroidism and WD and the first in a live patient with excellent recovery.
- Barrere X, Valeix P, Preziosi P, Bensimon M, Pelletier B, Galan P, Hercberg S: Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clin Endocrinol. 2000, 52: 273-278. 10.1046/j.1365-2265.2000.00939.x.View ArticleGoogle Scholar
- Ramzan NN, Loftus E, Burgart LJ, Rooney M, Batts KP, Wiesner RH, Fredricks DN, Relman DA, Persing DH: Diagnosis and monitoring of Whipple's disease by polymerase chain reaction. Ann Intern Med. 1997, 126: 520-27.View ArticlePubMedGoogle Scholar
- Misbah SA, Aslam A, Costello C: Whipple's disease. Lancet. 2004, 363: 654-56. 10.1016/S0140-6736(04)15600-6.View ArticlePubMedGoogle Scholar
- Misbah SA, Mapstone NP: Whipple's disease revisited. J Clin Pathol. 2000, 53: 750-55. 10.1136/jcp.53.10.750.View ArticlePubMedPubMed CentralGoogle Scholar
- Marth T, Raoult D: Whipple's disease. Lancet. 2003, 361: 239-46. 10.1016/S0140-6736(03)12274-X.View ArticlePubMedGoogle Scholar
- Street S, Donoghue HD, Neild GH: Tropheryma whippelii DNA in saliva of healthy people. Lancet. 1999, 354: 1178-1179. 10.1016/S0140-6736(99)03065-2.View ArticlePubMedGoogle Scholar
- Maiwald M, Schuhmacher F, Ditton HJ, von Herbay A: Environmental occurrence of the Whipple's disease bacterium (Tropheryma whippelii). Appl Environ Microbiol. 1998, 64: 760-762.PubMedPubMed CentralGoogle Scholar
- Ehrbar H-U, Bauerfeind P, Dutly F, Koel H-U, Altwegg M: PCR-positive tests for Tropheryma whippelii in patients without Whipple's disease. Lancet. 1999, 353: 2214-10.1016/S0140-6736(99)01776-6.View ArticlePubMedGoogle Scholar
- Raoult D, La Scola B, Lecocq P, Lepidi H, Fournier P-E: Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease. JAMA. 2001, 285: 1039-1043. 10.1001/jama.285.8.1039.View ArticlePubMedGoogle Scholar
- Fenollar F, Raoult D: Whipple's disease. Clin Diagn Lab Immunol. 2001, 8: 1-8. 10.1128/CDLI.8.1.1-8.2001.PubMedPubMed CentralGoogle Scholar
- Hays M: Localisation of human thyroxine absorption. Thyroid. 1991, 1: 241-8.View ArticlePubMedGoogle Scholar
- Wenzel KW, Kirschsieper HE: Aspects of the absorption of oral L-thyroxine in a normal man. Metabolism. 1977, 26: 1-8. 10.1016/0026-0495(77)90121-4.View ArticlePubMedGoogle Scholar
- Poveda J-D, Puechal X, Saad R: Tropheryma whippelii in synovial tissue and fluid. Ann Intern Med. 1999, 131: 795-6.PubMedGoogle Scholar
- Gordon RY, Blumber E, Brozena SC, Fyfe B: Whipple pancarditis as a cause of heart failure. Ann Intern Med. 2004, 140: 673-4.View ArticlePubMedGoogle Scholar
- Dutly F, Altwegg M: Whipple's disease and "Tropheryma whippelii". Clin Microbiol Rev. 2001, 14: 561-83. 10.1128/CMR.14.3.561-583.2001.View ArticlePubMedPubMed CentralGoogle Scholar
- Brandle M, Ammann P, Spinas GA, Dutly F, Galeazzi RL, Schmid C, Altwegg M: Relapsing Whipple's disease presenting with hypopituitarism. Clin Endoc. 1999, 50: 399-403.View ArticleGoogle Scholar
- Marth T, Fredricks D, Strober W, Relman DA: Limited role for PCR-based diagnosis of Whipple's disease from peripheral blood mononuclear cells. Lancet. 1996, 348: 66-67. 10.1016/S0140-6736(05)64400-5.View ArticlePubMedGoogle Scholar
- von Herbay A, Ditton HJ, Schuhmacher F, Maiwald M: Whipple's disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology. 1997, 113: 434-441. 10.1053/gast.1997.v113.pm9247461.View ArticlePubMedGoogle Scholar
- Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J: Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996, 40: 561-568. 10.1002/ana.410400404.View ArticlePubMedGoogle Scholar
- Rodarte JR, Garrison CO, Holley KE, Fontana RS: Whipple's disease simulating sarcoidosis. A case with unique clinical and histologic features. Arch Intern Med. 1972, 129: 479-482. 10.1001/archinte.129.3.479.View ArticlePubMedGoogle Scholar
- Staub J-J, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD: Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992, 92: 631-42. 10.1016/0002-9343(92)90782-7.View ArticlePubMedGoogle Scholar
- Muller B, Zulewski H, Huber P, Ratcliff JG, Staub J-J: Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med. 1995, 333: 964-9. 10.1056/NEJM199510123331503.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/6/3/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.